 Health Canada approves Ultragenyx Pharmaceutical Incs NASDAQ: RARE Dojolvi triheptanoin as a source of calories and fatty acids for the treatment of adult and pediatric patients with long-chain fatty acid oxidation disorders LC-FAOD. LC-FAOD are a group of rare, genetic, metabolic deficiencies caused by defects in the enzymes needed to produce energy from fatty acids. 